| Bioactivity | Polyinosinic-polycytidylic acid LMW is a low molecular weight polyinosine-polycytidylic acid. Polyinosinic-polycytidylic acid LMW is a TLR3 agonist[1][2]. |
| CAS | 24939-03-5 |
| Formula | (C10H13N4O8P)x.(C9H14N3O8P)x |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Correia-Pinto JF, et al. Chitosan-Poly (I:C)-PADRE Based Nanoparticles as Delivery Vehicles for Synthetic Peptide Vaccines. Vaccines (Basel). 2015 Sep 11;3(3):730-50. [2]. Dai X, et al. Co-delivery of polyinosinic:polycytidylic acid and flagellin by poly(lactic-co-glycolic acid) MPs synergistically enhances immune response elicited by intranasally delivered hepatitis B surface antigen. Int J Nanomedicine. 2017 Sep 7;12:6617-6632. |
Polyinosinic-polycytidylic acid LMW
CAS: 24939-03-5 F: (C10H13N4O8P)x.(C9H14N3O8P)x W:
Polyinosinic-polycytidylic acid LMW is a low molecular weight polyinosine-polycytidylic acid. Polyinosinic-polycytidylic
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.